TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01997333 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT04016116 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT00352547 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00352547 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00747591 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT03010280 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04313270 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT01971008 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00291382 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT01880242 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT02484352 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00666510 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02534727 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT04950946 — Predictive Biomarker (PRD): GNAO1 mRNA
Genes: GNAO1
Study NCT01731262 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT04560751 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT01841749 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT00815841 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02367196 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT04613076 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03225898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02431975 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03525613 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02767661 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00777361 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00321815 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01322711 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00938444 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01982461 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00887510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03466736 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00582725 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02528461 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT01920061 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01920061 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study NCT01844310 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT00859937 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01377298 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02811237 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02806492 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00303927 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01286779 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study NCT03330795 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04439708 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00513162 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02407210 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01947712 — Predictive Biomarker (PRD): CYBB mRNA
Genes: CYBB; NOX2
Study NCT01276769 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02221999 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00592995 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03356912 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03356912 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT00989963 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00989963 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03796078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02389322 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03432468 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03925636 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00919282 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT01230476 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02876848 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02876848 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01632189 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT04411134 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01276678 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01276678 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04570696 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT06636435 — Predictive Biomarker (PRD): DLK1 mRNA
Genes: DLK1; DLK
Study NCT01617499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00786643 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00293540 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01773915 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00529828 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00529828 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01025505 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01025505 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04641013 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02608736 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT02608736 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02608736 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT02389634 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02180451 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT03908684 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04765969 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT04765969 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT00036972 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT01511952 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02255110 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT02255110 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01311986 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study NCT01311986 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study NCT01311986 — Predictive Biomarker (PRD): CCL22 mRNA
Genes: CCL22; MDC; SCYA22; A-152E5.1
Study NCT01311986 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT00278044 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT01623869 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study NCT04373746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02879838 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT06015776 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT03162445 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06574061 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00410332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03752658 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01294761 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT03740087 — Safety Biomarker (SAF): miR-1
Study NCT03740087 — Safety Biomarker (SAF): miR-22
Genes: MIR22
Study NCT03740087 — Safety Biomarker (SAF): miR-192
Genes: MIR192
Study NCT02838134 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT01289210 — Predictive Biomarker (PRD): TLR8 mRNA
Genes: TLR8; UNQ249/PRO286
Study NCT00097812 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00577421 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00187733 — Predictive Biomarker (PRD): SLC22A5 mRNA
Genes: SLC22A5; OCTN2
Study NCT03464682 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00727506 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT00727506 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00727506 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01228877 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04365504 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00066092 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02197923 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study NCT00150631 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01677234 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00815594 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00815594 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02449590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02449590 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02449590 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03774147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02760901 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03578900 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT03028597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01160627 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01078636 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03640221 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03640221 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01603849 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00723762 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00723762 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00367731 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00284193 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01902186 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02447653 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00449345 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02265809 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04715971 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01803815 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02643147 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT02536742 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02536742 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04292314 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02983578 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT04674345 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02222220 — Safety Biomarker (SAF): DRD3
Study NCT00134355 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00134355 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00001317 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00393497 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00390078 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00260247 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04608747 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04608747 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02671669 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03088345 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02486783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04611802 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03391843 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04488731 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02818205 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT02023359 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03553381 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02564198 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00005854 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00005854 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT00005854 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study NCT00005854 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT00145132 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT00145132 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT01131104 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00404339 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01954706 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00524186 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01156753 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT01952340 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00053482 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01682694 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02453061 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02557126 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03508947 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02605746 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01620970 — Predictive Biomarker (PRD): ALK
Genes: CD246; ALK1
Study NCT02572765 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02572765 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02689570 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01173978 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02391519 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT02422732 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02922283 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00422383 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02866669 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02714712 — Predictive Biomarker (PRD): SCARB1 mRNA
Genes: SCARB1; CD36L1; CLA1
Study NCT02098278 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT01514851 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT01491711 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT03669237 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT03248089 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00949247 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00949247 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00883298 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04356716 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01746147 — Predictive Biomarker (PRD): Liver iron
Study NCT00502502 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00502502 — Safety Biomarker (SAF): Interleukin 1
Study NCT00607672 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01996085 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01192061 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01418742 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02828202 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02828202 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02578485 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02578485 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01895959 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03116256 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05002179 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02003417 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03969498 — Safety Biomarker (SAF): Coagulation factor Va
Genes: F5
Study NCT03969498 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT00894504 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00894504 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00894504 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00894504 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01360385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01360385 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02577588 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02577588 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01259544 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00053131 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04088045 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03064425 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03482362 — Predictive Biomarker (PRD): RANBP2 mRNA
Genes: RANBP2; NUP358
Study NCT02168322 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03725761 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03294798 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02103114 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT00079755 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04236739 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01084226 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02830529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00825305 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01839734 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04371666 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00016289 — Safety Biomarker (SAF): Interleukin 12
Study NCT03076034 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03888573 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03272737 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00741234 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT01502592 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02357524 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01059305 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04530578 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02650830 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT04565665 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00018499 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02501486 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00500396 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00500396 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00689130 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00662545 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00822536 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00118612 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT03353597 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00672451 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01004523 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01218477 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study NCT00003649 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1